Two weeks into his tenure leading the FDA’s biologics center, Vinay Prasad has made his mark with a new framework for ...

The truth is that for most of that, for many Americans, we simply do not know the answer to whether or not they should be ...

The agency will now require randomized, controlled data before approving new COVID shots for healthy children and adults, ...

When you buy through links on our articles, Future and its syndication partners may earn a commission.

RANCHI: As many as seven serving Indian Administrative Service (IAS) officers have been jailed in corruption-related cases in ...

Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or ...

If there’s anything that Dr. Vinay Prasad, the controversial new appointee to lead the Center for Biologics Evaluation and Research, or CBER, a top office at the Food and Drug Administration ...

The FDA will continue recommending annual COVID-19 vaccines for older adults and high-risk groups, but says more clinical ...

At the American Society of Cell and Gene Therapy conference, there were questions and qualms on how Vinay Prasad may change ...

Healthy younger adults and children will no longer be automatically approved for annual COVID-19 vaccines under a new policy ...

A hot (if cautious) topic at the big gene therapy meeting: what Vinay Prasad's appointment might mean for approvals in rare ...